Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Placebo
Canagliflozin
Locations
1
United States
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Start Date
September 16, 2014
Primary Completion Date
May 1, 2019
Completion Date
September 3, 2019
Last Updated
March 4, 2025
NCT07310264
NCT06342713
NCT07472361
NCT06649110
NCT06823947
NCT07240675
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions